|
[9000452.] رقم البحث : 9000452 - |
|
Compliance of diabetic patients with the prescribed clinical regimen / |
| |
قطاع الدراسات الطبية / صحه المجتمع والصحه العامه |
| تخصص البحث : صحه المجتمع والصحه العامه |
| |
Menoufia Medical Journal / / Vol. 25, No. 2 - July 2012 |
| |
إيمان أحمد عطيه |
| |
clinical regimen, compliance, diabetes mellitus |
| |
Objectives
This study aimed at studying the prevalence of noncompliance among diabetic
patients in Gharbia governorate in Egypt as well its causes, its effect on glycemic
control, and factors affecting it.
Background
There is growing evidence suggesting that because of the alarmingly low rates of
compliance, increasing the effectiveness of compliance interventions may have a great
impact on the health of the population. Promotion of therapeutic compliance is
considered an integral component of patient care. It has been shown that despite
effective methods of treatment, many diabetic patients fail to achieve satisfactory
glycemic control, which leads to accelerated development of complications and
increased mortality.
Patients and methods
A total of 339 diabetic patients who fulfilled the inclusion criteria were recruited in
the present study. Compliance to treatment was evaluated during patients’ visits to
health units in Gharbia governorate. Medication compliance was assessed during
a personal interview with each patient using a multiple-choice questionnaire. Blood
samples were obtained for measurement of glycated hemoglobin (HbA1c).
Results
In the study population, the compliance rates were observed to be suboptimal. The
most important social factors that significantly affected compliance rates included age,
income, and educational level. Among the factors that significantly affected
compliance rates were duration of treatment, presence of diseases other than
diabetes, and the number of prescribed drugs. Another factor that played an important
role was diabetes care costs. The most common reasons for low rates of compliance
were forgetfulness and high cost of treatment.
Conclusion
An improvement in the compliance level may be achieved through improvement of
patients’ economic levels as well as reduction in the cost of medication. The number of
drugs and doses should be reduced as much as possible through continuous research
involving doctors and pharmaceutical companies. |
| |
 Download Paper |
تسجيل دخول 
